Skip to main content
Top
Published in: Clinical Oral Investigations 6/2010

Open Access 01-12-2010 | Original Article

Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease

Authors: Hui Chen, Pei Zheng, Haihua Zhu, Jianhua Zhu, Lili Zhao, Nour Eddine El Mokhtari, Jörg Eberhard, Markus Lins, Søren Jepsen

Published in: Clinical Oral Investigations | Issue 6/2010

Login to get access

Abstract

The purpose of the present study was to investigate systemic and local levels of platelet-activating factor (PAF), a potent proinflammatory mediator implicated in cardiovascular pathophysiology in adult nonsmoking patients with periodontitis with or without coronary heart disease (CHD). Eighty-seven volunteers, 25 periodontitis patients, 19 periodontitis with CHD patients, 19 CHD patients, and 24 healthy controls were included, and periodontal conditions were assessed. Gingival crevicular fluid (GCF) and venous blood were collected, and PAF levels were measured by enzyme-linked immunosorbent assay. PAF levels in serum (303.3 ± 204 pg/ml) and in GCF (26.3 ± 6 pg/μl) of the periodontitis group with CHD, the periodontitis group (serum, 302.4 ± 241 pg/ml and GCF, 26.3 ± 8 pg/μl) and the CHD group (serum, 284.7 ± 192 pg/ml and GCF, 20.8 ± 6 pg/μl) were significantly higher than the healthy control group (serum, 65.4 ± 35 pg/ml and GCF, 7.7 ± 3 pg/μl; p < 0.05). In summary, the present study could demonstrate that in patients with periodontitis, the inflammatory mediator PAF is released into serum at least in the same range as for patients with coronary heart disease. However, no additive effects were seen when both conditions were present.
Literature
1.
go back to reference Wu LL (1999) Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci 29:127–133PubMed Wu LL (1999) Review of risk factors for cardiovascular diseases. Ann Clin Lab Sci 29:127–133PubMed
2.
go back to reference Mehta JL, Saldeen TG, Rand K (1998) Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31:1217–1225CrossRefPubMed Mehta JL, Saldeen TG, Rand K (1998) Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31:1217–1225CrossRefPubMed
3.
go back to reference Leinonen M, Saikku P (2002) Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2:11–17CrossRefPubMed Leinonen M, Saikku P (2002) Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2:11–17CrossRefPubMed
4.
go back to reference Scannapieco FA, Genco RJ (1999) Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res 34:340–345CrossRefPubMed Scannapieco FA, Genco RJ (1999) Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res 34:340–345CrossRefPubMed
5.
go back to reference Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001) Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221–1227CrossRefPubMed Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001) Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221–1227CrossRefPubMed
6.
go back to reference Geerts SO, Legrand V, Charpentier J, Albert A, Rompen EH (2004) Further evidence of the association between periodontal conditions and coronary artery disease. J Periodontol 75:1274–1280CrossRefPubMed Geerts SO, Legrand V, Charpentier J, Albert A, Rompen EH (2004) Further evidence of the association between periodontal conditions and coronary artery disease. J Periodontol 75:1274–1280CrossRefPubMed
7.
go back to reference Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C (2004) Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 31:25–29CrossRefPubMed Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C (2004) Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol 31:25–29CrossRefPubMed
8.
go back to reference Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430–436CrossRefPubMed Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350:430–436CrossRefPubMed
9.
go back to reference Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419–445CrossRefPubMed Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419–445CrossRefPubMed
10.
go back to reference Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40:643–672CrossRefPubMed Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40:643–672CrossRefPubMed
11.
go back to reference Behrens TW, Goodwin JS (1990) Control of human T cell proliferation by platelet-activating factor. Int J Immunopharmacol 12:175–184CrossRefPubMed Behrens TW, Goodwin JS (1990) Control of human T cell proliferation by platelet-activating factor. Int J Immunopharmacol 12:175–184CrossRefPubMed
12.
go back to reference Denizot Y, Dupuis F, Praloran V (1994) Effects of platelet-activating factor on human T and B cells—an overview. Res Immunol 145:109–116CrossRefPubMed Denizot Y, Dupuis F, Praloran V (1994) Effects of platelet-activating factor on human T and B cells—an overview. Res Immunol 145:109–116CrossRefPubMed
13.
go back to reference Ninio E (2005) Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Curr Opin Clin Nutr Metab Care 8:123–131CrossRefPubMed Ninio E (2005) Phospholipid mediators in the vessel wall: involvement in atherosclerosis. Curr Opin Clin Nutr Metab Care 8:123–131CrossRefPubMed
14.
go back to reference Ghesquiere SA, Hofker MH, de Winther MP (2005) The role of phospholipases in lipid modification and atherosclerosis. Cardiovasc Toxicol 5:161–182CrossRefPubMed Ghesquiere SA, Hofker MH, de Winther MP (2005) The role of phospholipases in lipid modification and atherosclerosis. Cardiovasc Toxicol 5:161–182CrossRefPubMed
15.
go back to reference Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA (1999) Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086. Circ Res 85:311–318PubMed Subbanagounder G, Leitinger N, Shih PT, Faull KF, Berliner JA (1999) Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: in vitro and in vivo inhibition by WEB 2086. Circ Res 85:311–318PubMed
16.
go back to reference Mueller HW, Haught CA, McNatt JM, Cui K, Gaskell SJ, Johnston DA, Willerson JT (1995) Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ Res 77:54–63PubMed Mueller HW, Haught CA, McNatt JM, Cui K, Gaskell SJ, Johnston DA, Willerson JT (1995) Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ Res 77:54–63PubMed
17.
go back to reference Cox CP, Wardlow ML, Jorgensen R, Farr RS (1981) The presence of platelet-activating factor (PAF) in normal human mixed saliva. J Immunol 127:46–50PubMed Cox CP, Wardlow ML, Jorgensen R, Farr RS (1981) The presence of platelet-activating factor (PAF) in normal human mixed saliva. J Immunol 127:46–50PubMed
18.
go back to reference Emingil G, Cinarcik S, Baylas H, Huseyinov A (2001) Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 72:1032–1037CrossRefPubMed Emingil G, Cinarcik S, Baylas H, Huseyinov A (2001) Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 72:1032–1037CrossRefPubMed
19.
go back to reference Keles GC, Cetinkaya BO, Ayas B, Isildak I, Diraman E, Koprulu H, Acikgoz G (2007) Levels of gingival tissue platelet activating factor after conventional and regenerative periodontal surgery. Clin Oral Investig 11:369–376CrossRefPubMed Keles GC, Cetinkaya BO, Ayas B, Isildak I, Diraman E, Koprulu H, Acikgoz G (2007) Levels of gingival tissue platelet activating factor after conventional and regenerative periodontal surgery. Clin Oral Investig 11:369–376CrossRefPubMed
20.
go back to reference Zheng P, Chen H, Shi S, Jepsen S, Eberhard J (2006) Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. J Clin Periodontol 33:797–802CrossRefPubMed Zheng P, Chen H, Shi S, Jepsen S, Eberhard J (2006) Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. J Clin Periodontol 33:797–802CrossRefPubMed
21.
go back to reference Zhou H, McCombs GB, Darby ML, Marinak K (2004) Sulphur by-product: the relationship between volatile sulphur compounds and dental plaque-induced gingivitis. J Contemp Dent Pract 5:27–39PubMed Zhou H, McCombs GB, Darby ML, Marinak K (2004) Sulphur by-product: the relationship between volatile sulphur compounds and dental plaque-induced gingivitis. J Contemp Dent Pract 5:27–39PubMed
22.
go back to reference Lamster IB, Oshrain RL, Celenti R, Levine K, Fine JB (1991) Correlation analysis for clinical and gingival crevicular fluid parameters at anatomically related gingival sites. J Clin Periodontol 18:272–277CrossRefPubMed Lamster IB, Oshrain RL, Celenti R, Levine K, Fine JB (1991) Correlation analysis for clinical and gingival crevicular fluid parameters at anatomically related gingival sites. J Clin Periodontol 18:272–277CrossRefPubMed
23.
go back to reference Iacopino AM, Cutler CW (2000) Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 71:1375–1384CrossRefPubMed Iacopino AM, Cutler CW (2000) Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 71:1375–1384CrossRefPubMed
24.
go back to reference Cutler CW, Shinedling EA, Nunn M, Jotwani R, Kim BO, Nares S, Iacopino AM (1999) Association between periodontitis and hyperlipidemia: cause or effect? J Periodontol 70:1429–1434CrossRefPubMed Cutler CW, Shinedling EA, Nunn M, Jotwani R, Kim BO, Nares S, Iacopino AM (1999) Association between periodontitis and hyperlipidemia: cause or effect? J Periodontol 70:1429–1434CrossRefPubMed
25.
go back to reference Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996) Periodontal disease and cardiovascular disease. J Periodontol 67:1123–1137PubMed Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996) Periodontal disease and cardiovascular disease. J Periodontol 67:1123–1137PubMed
26.
go back to reference Arbes SJ Jr, Slade GD, Beck JD (1999) Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 78:1777–1782CrossRefPubMed Arbes SJ Jr, Slade GD, Beck JD (1999) Association between extent of periodontal attachment loss and self-reported history of heart attack: an analysis of NHANES III data. J Dent Res 78:1777–1782CrossRefPubMed
27.
go back to reference Mattila KJ, Asikainen S, Wolf J, Jousimies-Somer H, Valtonen V, Nieminen M (2000) Age, dental infections, and coronary heart disease. J Dent Res 79:756–760CrossRefPubMed Mattila KJ, Asikainen S, Wolf J, Jousimies-Somer H, Valtonen V, Nieminen M (2000) Age, dental infections, and coronary heart disease. J Dent Res 79:756–760CrossRefPubMed
28.
go back to reference Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71:1554–1560CrossRefPubMed Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ (2000) Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71:1554–1560CrossRefPubMed
29.
go back to reference Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kuhbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Gunther R, Kruger D, Lins M, Herrmann G, Folsch UR, Simon R, Schreiber S (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113:929–937CrossRefPubMed Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kuhbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Gunther R, Kruger D, Lins M, Herrmann G, Folsch UR, Simon R, Schreiber S (2006) Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113:929–937CrossRefPubMed
30.
go back to reference Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94:874–877PubMed Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A (1996) Elevated levels of interleukin-6 in unstable angina. Circulation 94:874–877PubMed
31.
go back to reference Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733PubMed Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731–733PubMed
32.
go back to reference Berk BC, Weintraub WS, Alexander RW (1990) Elevation of C-reactive protein in “active” coronary artery disease. Am J Cardiol 65:168–172CrossRefPubMed Berk BC, Weintraub WS, Alexander RW (1990) Elevation of C-reactive protein in “active” coronary artery disease. Am J Cardiol 65:168–172CrossRefPubMed
33.
go back to reference Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528–1534CrossRefPubMed Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528–1534CrossRefPubMed
34.
go back to reference Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13:93–100CrossRefPubMed Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13:93–100CrossRefPubMed
35.
go back to reference Montrucchio G, Alloatti G, Camussi G (2000) Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669–1699PubMed Montrucchio G, Alloatti G, Camussi G (2000) Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669–1699PubMed
36.
go back to reference Montrucchio G, Camussi G, Tetta C, Emanuelli G, Orzan F, Libero L, Brusca A (1986) Intravascular release of platelet-activating factor during atrial pacing. Lancet 2:293CrossRefPubMed Montrucchio G, Camussi G, Tetta C, Emanuelli G, Orzan F, Libero L, Brusca A (1986) Intravascular release of platelet-activating factor during atrial pacing. Lancet 2:293CrossRefPubMed
37.
go back to reference Miyaura S, Eguchi H, Johnston JM (1992) Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res 70:341–347PubMed Miyaura S, Eguchi H, Johnston JM (1992) Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ Res 70:341–347PubMed
38.
go back to reference Iatrou C, Moustakas G, Antonopoulou S, Demopoulos CA, Ziroyiannis P (1996) Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Nephron 72:611–616CrossRefPubMed Iatrou C, Moustakas G, Antonopoulou S, Demopoulos CA, Ziroyiannis P (1996) Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis. Nephron 72:611–616CrossRefPubMed
39.
go back to reference D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156–160CrossRefPubMed D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156–160CrossRefPubMed
40.
go back to reference Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979CrossRefPubMed Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979CrossRefPubMed
41.
go back to reference Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM (1996) Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta 1301:161–173PubMed Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM (1996) Mammalian platelet-activating factor acetylhydrolases. Biochim Biophys Acta 1301:161–173PubMed
42.
go back to reference Lamster IB, Oshrain RL, Gordon JM (1986) Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 13:799–804CrossRefPubMed Lamster IB, Oshrain RL, Gordon JM (1986) Enzyme activity in human gingival crevicular fluid: considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 13:799–804CrossRefPubMed
43.
go back to reference Keles GC, Cetinkaya BO, Isildak I, Koprulu H, Acikgoz G (2006) Levels of platelet activating factor in gingival crevice fluid following periodontal surgical therapy. J Periodontal Res 41:513–518CrossRefPubMed Keles GC, Cetinkaya BO, Isildak I, Koprulu H, Acikgoz G (2006) Levels of platelet activating factor in gingival crevice fluid following periodontal surgical therapy. J Periodontal Res 41:513–518CrossRefPubMed
44.
go back to reference Rasch MS, Mealey BL, Prihoda TJ, Woodard DS, McManus LM (1995) The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis. J Periodontol 66:613–623PubMed Rasch MS, Mealey BL, Prihoda TJ, Woodard DS, McManus LM (1995) The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis. J Periodontol 66:613–623PubMed
45.
go back to reference McManus LM, Marze BT, Schiess AV (1990) Deficiency of salivary PAF in edentulous individuals. J Periodontal Res 25:347–351CrossRefPubMed McManus LM, Marze BT, Schiess AV (1990) Deficiency of salivary PAF in edentulous individuals. J Periodontal Res 25:347–351CrossRefPubMed
46.
go back to reference Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, Montaye M, Amouyel P, Ferrieres J, Ruidavets JB, Evans A, Bingham A, Ducimetiere P (2005) Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 34:268–275CrossRefPubMed Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, Montaye M, Amouyel P, Ferrieres J, Ruidavets JB, Evans A, Bingham A, Ducimetiere P (2005) Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol 34:268–275CrossRefPubMed
Metadata
Title
Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease
Authors
Hui Chen
Pei Zheng
Haihua Zhu
Jianhua Zhu
Lili Zhao
Nour Eddine El Mokhtari
Jörg Eberhard
Markus Lins
Søren Jepsen
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Clinical Oral Investigations / Issue 6/2010
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-009-0346-5

Other articles of this Issue 6/2010

Clinical Oral Investigations 6/2010 Go to the issue